Photo of Sharad A Ghamande

View Scopus Profile

Sharad A Ghamande

Department Chair

  • 931 Citations
  • 17 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Sharad A Ghamande is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Georgia CaRes

Ghamande, S. A.

Project: Research project

GHSU Minority-Based Community Clinical Oncology Program

Ghamande, S. A.

Project: Research project

Research Output

  • 931 Citations
  • 17 h-Index
  • 38 Article
  • 2 Letter

A 73-gene proliferative transcriptomic signature predicts uterine serous carcinoma patient survival and response to primary therapy

Tran, L. K. H., Tran, P. M. H., Mysona, D. P., Purohit, S. B., Myers, E., Lee, W. S., Dun, B., Xu, D., Liu, H., Hopkins, D., Nechtman, J., Scelsi, C. L., Mittal, P. K., Kleven, D. T., Wallbillich, J. J., Rungruang, B., Ghamande, S. & She, J. X., Jan 1 2020, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journal › Article

    • A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer

    Oza, A. M., Matulonis, U. A., Secord, A. A., Nemunaitis, J., Roman, L. D., Blagden, S. P., Banerjee, S., McGuire, W. P., Ghamande, S., Birrer, M. J., Fleming, G. F., Markham, M. J., Hirte, H. W., Provencher, D. M., Basu, B., Kristeleit, R., Armstrong, D. K., Schwartz, B., Braly, P., Hall, G. D. & 8 others, Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Hao, Y., Keer, H., Azab, M. & Matei, D., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1009-1016 8 p.

    Research output: Contribution to journal › Article

    • 6 Scopus citations

    Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers

    Mysona, D. P., Tran, L. K. H., Tran, P. M. H., Gehrig, P. A., Van Le, L., Ghamande, S., Rungruang, B. J., Java, J., Mann, A. K., Liao, J., Kapp, D. S., Santos, B. D., She, J. X. & Chan, J. K., Jan 2020, In : Gynecologic Oncology. 156, 1, p. 77-84 8 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer

    Arend, R. C., Davis, A. M., Chimiczewski, P., O'Malley, D. M., Provencher, D., Vergote, I., Ghamande, S. & Birrer, M. J., Feb 2020, In : Gynecologic Oncology. 156, 2, p. 301-307 7 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Sequential Ipilimumab after Chemoradiotherapy in Curative-Intent Treatment of Patients with Node-Positive Cervical Cancer

    Mayadev, J. S., Enserro, D., Lin, Y. G., Da Silva, D. M., Lankes, H. A., Aghajanian, C., Ghamande, S., Moore, K. N., Kennedy, V. A., Fracasso, P. M. & Schilder, R. J., Jan 2020, In : JAMA Oncology. 6, 1, p. 92-99 8 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations